Status:
COMPLETED
Image-Guided Gynecologic Brachytherapy
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Cervical Cancer
Uterine Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Standard therapy for gynecologic cancers involves the use of brachytherapy, also called internal radiation therapy or implant radiation. The treatment being studied consists of standard brachytherapy ...
Detailed Description
The insertion of the brachytherapy applicator will be administered in the Advanced Multimodality Image-Guided Operating (AMIGO) suite at Brigham and Women's Hospital. Subjects will undergo an MRI scan...
Eligibility Criteria
Inclusion
- Histologically or cytologically confirmed carcinoma of the cervix (Stage I-IVA), carcinoma of the uterus (Stage IIIB), carcinoma of the vagina (Stage I-IVA), or carcinoma of the vulva (stage I-IVA)
- Life expectancy \> 6 months
- MRI of the pelvis and/or PET-CT within 4 months prior to entering study
Exclusion
- Uncontrolled intercurrent illness
- Pacemaker, brain aneurysm clip, inner ear implant, neurostimulator, or metal fragments in the eye
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT01399658
Start Date
September 1 2011
End Date
June 1 2016
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02215